✦ LIBER ✦

Safety and effectiveness of long-term budesonide treatment in maintaining remission in patients with mild-to-moderate Crohn's disease

✍ Scribed by Antonio Tursi; Gian Marco Giorgetti; Giovanni Brandimarte; Walter Elisei

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 64 KB
Volume: 13
Category: Article
ISSN: 1078-0998
DOI: 10.1002/ibd.20145

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

How adherent to treatment with azathiopr

How adherent to treatment with azathioprine are patients with Crohn's disease in long-term remission?

✍ Gerassimos J. Mantzaris; Anastasios Roussos; Chryssostomos Kalantzis; Stavroula 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

## Background: Patients with longstanding quiescent crohn's disease on azathioprine usually maintain an excellent quality of life but are also concerned about long-term safety. this may affect adherence to treatment. the aim of the present study was to assess the adherence to azathioprine in a coho

Safety and tolerability of concurrent na

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

✍ Bruce E. Sands; Richard Kozarek; Jack Spainhour; Charles F. Barish; Scott Becker 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 1 views

Safety and tolerability of concurrent na

Safety and tolerability of concurrent natalizumab treatment for patients with Crohn's disease not in remission while receiving infliximab

✍ Bruce E. Sands; Richard Kozarek; Jack Spainhour; Charles F. Barish; Scott Becker 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 326 KB 👁 1 views

## Background: Natalizumab, a humanized monoclonal igg(4) antibody to alpha4 integrin, was investigated as a treatment of active crohn's disease (cd). the safety of natalizumab given in combination with infliximab has not previously been studied. ## Methods: Seventy-nine adult patients with activ

Long-term remission after cessation of i

Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet's disease

✍ Christoph M. E. Deuter; Manfred Zierhut; Antje Möhle; Reinhard Vonthein; Nicole 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 469 KB 👁 1 views

Detecting treatment effects with combina

Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease

✍ Ralf Ihl; Steven Ferris; Philippe Robert; Bengt Winblad; Serge Gauthier; Frank T 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

## Abstract ## Objective When complex cognitive functions are measured with multi‐item scales like the Alzheimer's Disease Assessment Scale – cognitive subscale (ADAS‐cog), it seems valuable information can be lost due to combination of the ADAS‐cog items results into a total score. We hypothesize

Impacts of long-term enteral nutrition o

Impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal cytokines during remission in patients with Crohn's disease: A prospective study

✍ Takayuki Yamamoto; Maki Nakahigashi; Abbi R. Saniabadi; Takashi Iwata; Yasuki Ma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 1 views

## Background: Long-term enteral nutrition may maintain clinical and endoscopic remission in patients with crohn's disease (cd). the aim of this prospective study was to investigate the impacts of long-term enteral nutrition on clinical and endoscopic disease activities and mucosal tissue cytokines